A profile of 60 patients of cutaneous leishmaniasis visiting Dermatology Departments of Hayatabad Medical Complex and Lady Reading Hospital, Peshawar

Authors

  • Shad Mohammad Wazir Dermatology Unit, Hayatabad Medical Complex Peshawar
  • Abdur Rahim Khan Dermatology Unit, Hayatabad Medical Complex Peshawar
  • Samiullah Khan Dermatology Unit, Lady Reading Hospital Peshawar

DOI:

https://doi.org/10.66344/jpad.v24i3.212

Keywords:

Cutaneous leishmaniasis, type of skin lesions, duration

Abstract

Objective To document the profile of patients of cutaneous leishmaniasis (CL) visiting Dermatology departments of Hayatabad Medical Complex & Lady Reading Hospital, Peshawar. 

Methods Irrespective of age and sex, a total of 60 patients with a clinical diagnosis of CL were enrolled for the study. 

Results A total of 38 male and 22 female patients were enrolled for this study. Age range of the patients was 15 months to 50 years. A sizeable number of patients presented with nodular presentation.

Conclusion CL is usually seen in males on exposed areas as noduloulcerative lesions.

References

1. Vega-Lopez F, Hay RJ. Parasitic worms and protozoa. In: Burns T, Breathnach S, Cox N, Griffith C, eds. Rook’s Textbook of Dermatology, 8th end. Oxford: Blackwell Science; 2010. P.37.1-37.44.

2. Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine, 2nd edn. Oxford: Oxford University Press, 1987.

3. Bhutto AM, Soomro RA, Nonaka S, Hashiguchi Y. Detection of new endemic areas of cutaneous leishmaniasis in Pakistan: a 6 year study. Int J Dermatol. 2003;42:543-8.

4. Abadeer A, Patel A, Haider S. Systemic therapy of New World cutaneous leishmaniasis: A case report and review article. Can J Infect Dis Microbiol. 2010;21:e79-e83.

5. Arevalo I, Ward B, Miller R et al. Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infec Dis. 2001;33:1847-1851.

6. Ayub S, Khalid M, Mujtaba G, Bhutta RA. Profile of patients of cutaneous leishmaniasis from Multan. J Pak Assoc Dermatol. 2001;11:279-81.

7. Kicarslan S, Turan E, Ekinci T et al. Clinical and histopathological characteristics of cutaneous leishmaniasis in Sanlifura city of Turkey including Syrian refugees. Indian J Pathol Microbiol. 2013;56:211-5.

8. Machado P, Araujo C, da Silva AT et al. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. Clin Infect Dis. 2002;34:e69-e73.

9. Schwartz C, Hatz C, Blum J. New world cutaneous leishmaniasis in travellers. Lancet Infect Dis. 2006;6:342-9.

10. Soto JM, Toledo JT, Guitieriz P et al. Treatment of cutaneous leishmaniasis with a topical antileishmania drug (WR279396): phase 2 pilot study. Am J Trop Med Hyg. 2002;66:147-51.

Downloads

Published

02.12.2016

Issue

Section

Original Articles

How to Cite

1.
A profile of 60 patients of cutaneous leishmaniasis visiting Dermatology Departments of Hayatabad Medical Complex and Lady Reading Hospital, Peshawar. J Pak Assoc Dermatol [Internet]. 2016 Dec. 2 [cited 2026 Jul. 23];24(3):256-8. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/212